Hello all.
Figured you may have already seen this but since I did not see it specifically here - I thought I would drop the link so you don’t have to find it.
The Congressional Research Service has put out a 4-page update about the legal implications of rescheduling cannabis from Schedule I to Schedule III.
For all those saying that the executive branch hasn’t been working on this - I find it quite compelling that we get the HHS announcement, then 6-months later the DEA announcement, and then 3 days later the CRS annoucement.
The process is alive and well it seems to me.
Nothing terribly new or notable was mentioned in this review - all things we have discussed broadly here on the forum. Including that even with rescheduling it will still be a federal crime to be a cannabis operator (medical or otherwise) in the US. And that only the FDA has the ability to approve new drugs for marketing in the US.
Congress needs to do more if we want things to be better. That’s why I’m headed to DC. I’d love to hear what you want to say to them. I’ll deliver letters in person to your representative if you like. Feel free to share. Or come to cannabis caucus lobby week in DC next week and join me and dozens (maybe even hundreds!) of others beating feet, shaking hands, and bending ears to change these laws.